Order Article Reprints

Di Minno A, Orsini RC, Chiesa M, Cavalca V, Calcaterra I, Tripaldella M, Anesi A, Fiorelli S, Eligini S, Colombo GI, et al. Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic Approach. Biomedicines. 2021; 9(8):1073. https://doi.org/10.3390/biomedicines9081073

Di Minno, Alessandro, Roberta Clara Orsini, Mattia Chiesa, Viviana Cavalca, Ilenia Calcaterra, Maria Tripaldella, Andrea Anesi, Susanna Fiorelli, Sonia Eligini, Gualtiero I. Colombo, and et al. 2021. "Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic Approach" Biomedicines 9, no. 8: 1073. https://doi.org/10.3390/biomedicines9081073

Di Minno, A., Orsini, R. C., Chiesa, M., Cavalca, V., Calcaterra, I., Tripaldella, M., Anesi, A., Fiorelli, S., Eligini, S., Colombo, G. I., Tremoli, E., Porro, B., & Di Minno, M. N. D. (2021). Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic Approach. Biomedicines, 9(8), 1073. https://doi.org/10.3390/biomedicines9081073